The Negatives Have Started to Matter<br />By Rev Shark<br />RealMoney.com Contributor<br />11/15/2007 7:53 AM EST <br /><br /><br />Somehow our devils are never quite what we expect when we meet them face to face. <br />-- Nelson DeMille<br /><br />For many months, the major indices have moved steadily higher as they ignored a slew of negatives. The bears were greatly frustrated as the market simply shrugged off bad-debt issues, a slowing economy, lousy real estate and high oil. Even after we suffered a sharp selloff in August on bad-debt issues, the market came roaring back as investors counted on the Fed to ease the pain. <br /><br />Nothing much has changed recently as far as the many negatives we face, but the mood of market players has soured considerably. That stubborn optimism that has served the market so well has eroded, and the confidence that it is safe to pile into a few big-cap technology stocks has abruptly come to an end. <br /><br />Such shifts in mood without a major change in the news is simply the nature of the market. Market players tend to focus on the reasons for market movement only after such moves occur. With the market off its highs, it is now easy and convenient to focus on all those negatives that have always been there. <br /><br />The good news for this market is that there is no secret as to the devils that are plaguing us. Right now, the continued bad-debt write-offs in the financial sector are the prime focus. There is no surprise negative news hitting us. We just don't know the extent of the issues that we are worrying about. The market does not like uncertainty because it can't price it in, and that is the big problem right now. <br /><br />Another problem for the market right now is that another potential rate cut by the Fed is failing to reassure investors. In August and September, the Fed anticipation was the primary reason the market bounced so strongly. The Fed is very likely to cut again in the near future, but the market is not taking any great comfort in that fact. We have the CPI report this morning, which, if benign, may help to bolster some optimism about the Fed making another cut. That could get something going, but the market is no longer perceiving a cut as the magic bullet to cure all ills. <br /><br />Many market players were hopeful that we might see another "V"-shaped market recovery after the huge bounce on Tuesday. The dreary close yesterday called that into question, but it doesn't mean the market is doomed at this point. Action like yesterday is far more typical after a big bounce than a straight-up recovery. Markets tend to be healthier and bottom out better when we have a series of failed spikes and bounces that shakes out weak hands and short terms. This action will actually serve us well for a rally as we enter the seasonally positive time of the year. <br /><br />We have a soft open this morning as more bad-debt write-offs hit, but the focus is on CPI. Overseas markets were mostly negative. Oil and gold are trading down. <br />----------------------------<br />Ülespoole avanevad:<br /><br />On strong earnings/guidance: ADLS + 31.6%, TSTC +22.0%, CHIC +18.8% , KLIC +13.6% , STP +11.0% , DIET +10.7% , FUQI +10.2% , WGOV +10.0% , BID +9.2% , PETM +6.4% , GSI +5.5% , FCSX +4.4% , INOD +3.6%, HP + 3.3%, FSYS + 3.1%, ANST +2.4% , TTEK +2.4% , PBI +2.1% (increase share repurchase), NUAN +1.7% , NTAP +1.5% , PODD +1.3% , PII+ 1.2%; Other news: LOCM +20.6% (begins liscencing local search technology), CMZ +9.2% (Icahn Mgmt reports new Compton Pete stake -- DJ), KMX +6.0% (Buffett reports holding 14 mln Carmax shares at Sept 30 -- DJ), NDN +5.7%, PLCE +4.4% (Icahn reports new Children's Place retail stores stake -- DJ), AMLN +3.9% (announces Pramlintide and Leptin weight loss results), BMY +3.0% (IMCL and BMY drug results in improved survival of colorectal cancer), OZM +2.9% (went public in IPO yesterday), IMCL +2.8% (IMCL and BMY drug results in improved survival of colorectal cancer), IACI +2.7% , MOGN +2.7% (Icahn Mgmt reports new MGI Pharma stake -- DJ), GENZ +2.5% (Icahn Mgmt reports new Genzyme stake -- DJ), TTWO +2.1% (Icahn Mgmt Reports New Take-Two Interactive Stake -- DJ), WBC +1.9% (Buffett reports holding 2.7 mln Wabco shares at Sept 30 -- DJ), GME +1.7% (Cramer gives positive comments on Mad Money), HD +1.7%, IGTE +1.6% (announces shareholder approval of delisting transaction), MER +1.2% (confirms John Thain named Chairman and Chief Executive Officer), BMY +0.5% (New England Journal of Medicine study shows ERBITUX improves survival in Advanced Colorectal Cancer) Solar stocks showing strength: TSL +4.5%, JASO +1.8%; Uprades: TMX +4.5% (upgraded to Buy at Citigroup), VCLK +3.5% (upgraded to buy at Citigroup), AVCT +1.9% (upgraded to Buy at ThonkEquity), AMZN +1.7% (upgraded to Buy at Stifel), MER +1.2% (upgraded to Neutral at Creit Suisse).<br /><br />Allapoole avanevad:<br /><br />On weak earnings/guidance: NFI -39.0%, SINA -9.1% (earnings and downgraded to Hold at Citigroup), DEEP -7.6% (earnings and new Chairman of Board), JCP -5.2% , AMAT -4.3%, AFCE -1.6%, WSM -0.9%; Other news: HSOA -9.1% (to delay Q3 Form 10-Q and conference call), BHP -3.7%, BEAS -3.7%(ORCL CEO made comments suggesting if another offer was made, the price would be lower, saying the $17 price seems too high now), GOLD -3.7%, THQI -3.3% (officer sells shares), SWN -2.8% (to expand customer base and pipeline system by more than 55% with purchase of Arkansas Natural Gas Utility), MTSN -2.6% (announces upcoming retirement of President and COO Robert MacKnight), GFI -1.6% (downgraded to Market Perform at BMOCapital), UBS -1.5% (WSJ reports expectations are growing of UBS Q4 write-downs of $7.1 bln), C -1.4% (WSJ reports expectations are growing of C Q4 write-downs of $8-11 bln).